Please select the option that best describes you:

Is there a role for extended adjuvant neratinib with pCR after neoadjuvant chemotherapy in triple positive breast cancer?   



Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Winship Cancer Institute and Emory University School of Medicine
In patients with HR+, HER2+ breast cancer who achi...
Medical Oncologist at Northwestern Medicine Cancer Center at KishHealth
Thanks.
Sign in or Register to read more